Does Rallies show live market data for CRBU?

Rallies combines live market context with ticker research for CRBU, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.

CRBU (Caribou Biosciences, Inc. Common Stock) Stock Analysis

Caribou Biosciences, Inc. Common Stock (CRBU) is a publicly traded Healthcare sector company. As of May 21, 2026, CRBU trades at $2.02 with a market cap of $205.30M and a P/E ratio of -1.24. CRBU moved +0.76% today. Year to date, CRBU is +24.22%; over the trailing twelve months it is +81.82%. Its 52-week range spans $0.66 to $3.54. Analyst consensus is strong buy with an average price target of $9.00. Rallies surfaces CRBU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest CRBU stock research?

Caribou Biosciences, Inc. Common Stock (CRBU) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CRBU moved +0.76% today. Analyst consensus is strong buy.

CRBU Key Metrics

Key financial metrics for CRBU
Metric	Value
Price	$2.02
Market Cap	$205.30M
P/E Ratio	-1.24
EPS	$-1.59
Dividend Yield	0.00%
52-Week High	$3.54
52-Week Low	$0.66
Volume	1.61M
Avg Volume	0
Revenue (TTM)	$11.16M
Net Income	$-148.13M
Gross Margin	0.00%

Latest CRBU News

Caribou to Present 84-Patient Vispa-cel Durability, 48-Patient CB-011 Follow-Up at EHA — May 12, 2026
Caribou Biosciences Q4 Loss Narrows to $0.28, Revenue Surges 56% to $3.94M — Mar 5, 2026
Caribou Biosciences Shows $148.1M GAAP Loss, Secures $142.8M Cash Runway — Mar 5, 2026
Caribou Biosciences Flags Funding Needs, Forecasts Q4 Loss and $734M CB-011 Sales — Feb 24, 2026
Caribou Biosciences Outlines Pivotal Phase II/III Vispa-cel Trial, Seeks $100M — Feb 23, 2026

Recent CRBU Insider Trades

Kelly Timothy P sold 6.23K (~$12.02K) on Feb 25, 2026.
Kelly Timothy P sold 3.15K (~$6.17K) on Feb 24, 2026.
MCCLUNG BARBARA G sold 6.94K (~$13.60K) on Feb 24, 2026.

CRBU Analyst Consensus

8 analysts cover CRBU: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.00.

Common questions about CRBU

What can I research for CRBU on Rallies?: Caribou Biosciences, Inc. Common Stock (CRBU) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CRBU moved +0.76% today. Analyst consensus is strong buy.
Does Rallies show live market data for CRBU?: Rallies combines live market context with ticker research for CRBU, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.